| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS10060123 | HBV | ENSG00000101981.12 | protein_coding | F9 | No | No | 2158 | P00740 |
| TVIS20001409 | HPV | ENSG00000101981.12 | protein_coding | F9 | No | No | 2158 | P00740 |
| TVIS20013114 | HPV | ENSG00000101981.12 | protein_coding | F9 | No | No | 2158 | P00740 |
| TVIS20021268 | HPV | ENSG00000101981.12 | protein_coding | F9 | No | No | 2158 | P00740 |
| TVIS20013113 | HPV | ENSG00000101981.12 | protein_coding | F9 | No | No | 2158 | P00740 |
| TVIS20046520 | HPV | ENSG00000101981.12 | protein_coding | F9 | No | No | 2158 | P00740 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | F9 |
|---|---|
| DrugBank ID | DB00170 |
| Drug Name | Menadione |
| Target ID | BE0000364 |
| UniProt ID | P00740 |
| Regulation Type | activator |
| PubMed IDs | 17348045 |
| Citations | Berkessel A, Guixa M, Schmidt F, Neudorfl JM, Lex J: Highly enantioselective epoxidation of 2-methylnaphthoquinone (vitamin K3) mediated by new cinchona alkaloid phase-transfer catalysts. Chemistry. 2007;13(16):4483-98. |
| Groups | Approved; Nutraceutical |
| Direct Classification | Naphthoquinones |
| SMILES | CC1=CC(=O)C2=CC=CC=C2C1=O |
| Pathways | |
| PharmGKB | PA450358 |
| ChEMBL | CHEMBL590 |
